TASOLYB Trademark
Trademark Overview
On Thursday, August 11, 2022, a trademark application was filed for TASOLYB with the United States Patent and Trademark Office. The USPTO has given the TASOLYB trademark a serial number of 97545153. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Wednesday, December 11, 2024. This trademark is owned by Glaxo Group Limited. The TASOLYB trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
General Information
| Serial Number | 97545153 |
| Word Mark | TASOLYB |
| Filing Date | Thursday, August 11, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Wednesday, December 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2024 |
Trademark Statements
| Goods and Services | Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Monday, August 15, 2022 | NEW APPLICATION ENTERED |
| Wednesday, August 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 30, 2023 | ASSIGNED TO EXAMINER |
| Thursday, June 1, 2023 | SUSPENSION LETTER WRITTEN |
| Thursday, June 1, 2023 | LETTER OF SUSPENSION E-MAILED |
| Thursday, June 1, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 12, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, July 12, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, July 12, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, September 28, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, January 10, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, February 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 8, 2024 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, October 8, 2024 | TEAS DELETE 1(B) BASIS RECEIVED |
| Monday, December 9, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 9, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Wednesday, December 11, 2024 | REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED |
| Wednesday, December 11, 2024 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
